Phase II Study of Bevacizumab and Temozolomide in Elderly Patients With Newly-Diagnosed Glioblastoma.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
- 24 Aug 2017 Planned End Date changed from 1 Jul 2018 to 1 Jan 2019.
- 24 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2018.
- 02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology